Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate by Aquaro, Gd et al.
IJC Metabolic & Endocrine 6 (2015) 17–23
Contents lists available at ScienceDirect
IJC Metabolic & Endocrine
j ourna l homepage: http : / /www. journa ls .e lsev ie r .com/ i jc -metabo l ic -and-endocr ineCardiac Metabolism in a Pig Model of Ischemia–Reperfusion by Cardiac
Magnetic Resonance with Hyperpolarized 13C-PyruvateGiovanni Donato Aquaro a,⁎, Francesca Frijia a, Vincenzo Positano a, Luca Menichetti b,
Maria Filomena Santarelli b, Vincenzo Lionetti c, Giulio Giovannetti b, Fabio Anastasio Recchia d, Luigi Landini a
a Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
b C.N.R. Institute of Clinical Physiology, Pisa, Italy
c Gruppo Intini-SMA Laboratory of Experimental Cardiology, Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy
d Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA⁎ Corresponding author at: Fondazione G. Monaste
G.Moruzzi, 1, 56124 Pisa, Italy. Tel.: +39 050 315 2818; f
E-mail address: aquaro@ftgm.it (G.D. Aquaro).
http://dx.doi.org/10.1016/j.ijcme.2015.01.007
2214-7624/© 2015 The Authors. Published by Elsevier Irelana b s t r a c ta r t i c l e i n f oArticle history:
Received 17 July 2014
Received in revised form 8 January 2015
Accepted 13 January 2015
Available online 19 January 2015
Keywords:
13C-pyruvate
Cardiac metabolism
Magnetic resonance
Ischemia/reperfusion
Background:Magnetic resonance (MRI) with hyperpolarized 13C-pyruvate is a new technique for the assessment
of myocardial metabolism.
Aims: The aim of this study is to assess the effectiveness of MRI with hyperpolarized 13C-pyruvate to detect car-
diac metabolic changes in a model of ischemia/reperfusion.
Methods: A pneumatic occluder was placed around the left anterior descending artery in 7 pigs. A 3 T scanner
with a 13C quadrature birdcage coil was used. Hyperpolarized 13C-pyruvate was injected intravenously at
rest, during coronary occlusion and 5 min after reperfusion. Metabolic images were acquired using a 3D-IDEAL
spiral CSI during the injection of 13C-pyruvate and 3D-parametric maps of 13C-pyruvate, 13C-lactate and 13C-
bicarbonate were generated. Metabolic Activity Mismatch (MAM) was defined as the relative change between
a) resting state and coronary occlusion or b) resting and reperfusion in all the myocardial segments.
Results: During occlusion, a decrease in 13C-lactate (−21 ± 26% vs baseline 3 ± 16%, P b 0.0001) and 13C-
bicarbonate (−29 ± 34% vs 33 ± 52%, P b 0.0001) was found in myocardial segments at risk, as compared
with remote segments. In ischemic segments, the 13C-lactate signal increased during reperfusion (20 ± 42% vs
−7 ± 22%, P=0.0007), while 13C-bicarbonate was persistently reduced (−38± 27% vs 36± 51%, p b 0.0001).
Conclusions: 13C-pyruvate MRI is able to detect transient changes in regional metabolism in an in-vivo model of
myocardial ischemia–reperfusion.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Magnetic resonance (MRI) with hyperpolarized 13C-labeled tracers
is an emerging imaging technique for the evaluation of coronary artery
anatomy, quantification of myocardial perfusion and a direct assess-
ment of myocardial viability [1]. In particular, MRI with hyperpolarized
13C-pyruvate has allowed, for the first time, to evaluate cardiac metab-
olism in real time and in vivo [2–4]. Relative changes of pyruvate and of
its metabolites lactate, alanine and bicarbonate can bemonitored under
normal conditions, during either acute ischemia or reperfusion, follow-
ing short- or long-lasting coronary occlusion [5]. Differently from PET
where FDG is not metabolized by myocites, the main advantage of
hyperpolarized 13C-pyruvate MRI is that the metabolic fate of 13C-
pyruvate and its metabolites is directly assessed. A recent study using
hyperpolarized 13C-pyruvate showed increased levels of 13C-lactaterio CNR-Regione Toscana, Via
ax: +39 050 315 2166.
d Ltd. This is an open access article unafter 10min of global ischemia in isolated hearts [6]. Golman et al. com-
bined conventional MRI scan and H13C by a single short-axis slice of
chemical shift images (CSI) in a pig model of ischemia–reperfusion,
demonstratingdecreased 13C-bicarbonate production in stunned viable
myocardial segments, after 15-minute coronary occlusion, and de-
creased 13C-bicarbonate and 13C-alanine production after 45-minute
occlusion [7]. Recently, Lau et al. proposed a three-dimensional multi-
slice cardiac-gated spiral 13C imaging approach, permitting whole-
heart coverage [8]. A novel fast three-dimensional acquisition (3D
IDEAL, Iterative DEcomposition of water and fat with Echo Asymmetric
and Least-squares estimation, spiral CSI pulse sequene)was then imple-
mented in a rat model, allowing a higher spatial resolution, over the
whole heart, of the spectral representation of single metabolites, sepa-
rately acquired [9,10].
The objective of this studywas to evaluate the capability and accura-
cy of MRI with hyperpolarized [1-13C]-pyruvate using the fast three-
dimensional pulse sequence to detect the presence and the regional
distribution of transient cardiac metabolic changes in a pig model of
ischemia/reperfusion.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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curacy of MRI with hyperpolarized [1-13C]-pyruvate using a 3D-IDEAL
Spiral CSI pulse sequence to detect the presence and the regional
distribution of metabolic changes in a pig model of acute ischemia and
ischemia/reperfusion.2. Methods
2.1. Pig instrumentation
Seven male pigs (38 ± 3 kg), fasted overnight, were sedated with a
cocktail of tiletamine hydrochloride and zolazepam hydrochloride
(8 mg kg−1 i.m.) and premedicated with atropine sulfate
(0.1 mg kg−1 i.m.). General anesthesia was subsequently induced
with propofol (2–4 mg kg−1 i.v.) and maintained with 1–2% isoflurane
in 50% air and 50% oxygen. Ventilation was adjusted based on arterial
blood gas values. U sterile conditions and a 3 mm diameter pneumatic
coronary occluder (Kent Scientific Corporation Torrington, Connecticut—
USA) was placed around the left anterior descending coronary artery
below the second diagonal branch through a direct thoracotomy at the
fifth intercostal space. After this procedure, the pigs were allowed to
fully recover for 10 days. Animal instrumentation and experimental pro-
tocolwere approvedby theAnimal Care Committee of the ItalianMinistry
of Health and was in accordance with the Italian law (DL-116, Jan. 27,
1992), which is in compliance with the National Institutes of Health pub-
lication Guide for the Care and Use of Laboratory Animals.2.2. MRI scanning
MRI was performed after post-surgical recovery. The pigs were se-
dated with continuous infusion of propofol (2–4 mg kg−1 h−1 i.v.)
and studied in spontaneous respiration. They were placed in the MRI
scanner laying on the right side. The hyperpolarized [1-13C]pyruvate
dose (0.13mmol/kg dissolved in 20ml of buffer solution) was adminis-
tered over 10 s by manual injection into the right ear vein. Injections
were performed at rest, during 2 min of full coronary occlusion and
after 5 min of reperfusion following 10 min of occlusion.Fig. 1. Comparison between the histological analysiswithmethylene-blue (upper panels) and 13
blue colorless segments corresponding tomiddle and apical anterior and anteroseptal myocard
in the 13C-lactate reconstructed images.Coronary occlusion was performed by injecting 2 ml of saline solu-
tion in the pneumatic occluder. Arterial O2 saturation, cardiac electric
activity and blood pressure were continuously monitored during the
experiment.
At the end of the MRI protocol the pigs were sacrificed by injecting
20 ml of KCl saturated solution after anesthesia induced by 20 ml
propofol. In four animals, the chestwas reopened, the coronary occluder
was inflated, the ascending aorta was clamped and 10 ml of 1% methy-
lene blue was injected into the coronary tree through the aortic wall, as
previously described [11]. Then the heart was excised, and 10mm thick
sliceswere cut and photographed. A qualitative and quantitative assess-
ment of the area at risk was performed and segments were classified as
normal or at risk (Fig. 1).2.3. Hyperpolarization and image acquisition
[1-13C]pyruvate polarizationwasperformedusingDynamicNuclear
Polarization (Hypersense, Oxford Instruments, Oxford, UK) [11]. The in-
jection solution contained 230mMof sodium [1-13C]pyruvate, 100mM
TRIS buffer, 0.27 mM Na 2EDTA and 20 microM Gd3+-complex
(Dotarem—Guerbet—France). The temperature of solution was approxi-
mately 37 °C and the pH≈ 7.6. In order to achieve the optimal timing to
lead the pyruvate conversion on its metabolites, i.e. lactate, alanine and
bicarbonate,MRI acquisition started 20 s after the endof the bolus injec-
tion [4].
Image acquisition was done in a 3-T GE Excite HDxt (GE Healthcare,
Waukesha, WI, USA) clinical scanner, using a 13C quadrature birdcage
coil (Rapid Biomedical, Würzburg, Germany) in low-pass version
(radius, 18.2 cm; length, 36 cm; 12 legs). The image acquisition protocol
included acquisition of anatomical reference images and CSI. Anatomi-
cal images were acquired with the scanner body coil and a 2D TOF
FSPGR sequence, ECG triggered, was used with TR = 16.6 ms, TE
2.7 ms, FOV = 30 × 30 cm, matrix 288 × 192. Twenty axial slices
were acquired with a slice thickness of 5 mm (no spacing) to cover
the entire heart. Metabolic information covering the heart were obtain-
ed using a 3D IDEAL spiral CSI prescribed on the same region imaged by
the reference anatomical sequence. The IDEAL spiral CSI is based on
single-shot spiral image encoding and echo-time shifting betweenC-lactate reconstructed images (lower panels). In the sections of excised heartmethylene-
ial segments represent the area at risk andmatchedwith the region with absence of signal
19G.D. Aquaro et al. / IJC Metabolic & Endocrine 6 (2015) 17–23excitations for the CSI encoding. 3D IDEAL spiral sequence was imple-
mented in axial plane (FOV= 30 × 30 cm2, slab thickness = 100 mm,
11 constant echo time shift of TE= 0.9 ms, FA= 7°, 14 phase encoding
steps along the z-direction)with a resolution of 15mm. The acquisition
time for the 3D-IDEAL spiral was of 17 s and the sequence started 20 s
after the beginning of the injection [4]. In addition, an FID spectrum is
also acquired, and the obtained CSI prior knowledge is effectively uti-
lized in the reconstruction,where it allowsmapping of the full spectrum
rather than a limited number of peaks at certain prescribed frequencies
[12].
The data were reconstructed using spectrally-preconditioned,
minimum-norm CSI inversion followed by gridding reconstruction im-
plemented in Matlab (The Mathworks, Inc., Natick, MA).2.4. Image analysis
Short axis (SA) views of left ventricle (LV) were reconstructed from
axial anatomical images by using Gate tool of PMOD software (PMOD
Technologies Ltd., Zurich, Switzerland). Briefly, the geometrical trans-
formation used to extract SA views was recorded and applied to meta-
bolic images that were reconstructed with the same orientation and
resolution of anatomical SA images. Hence, 20 SA slices were involved
in the image analysis process. Both anatomical and metabolic SA
views were stored in DICOM format. Fig. 2 shows a typical example of
corresponding anatomical and metabolic SA views extracted as previ-
ously described.
Quantitative analysis was performed on SA views by a custom soft-
ware tool (HIPPO C13) developed in IDL 8.0 (Exelis Visual Information
Solutions, Boulder, CO, USA). Myocardial contours were manually de-
fined in anatomical SA views covering the entire LV (Fig. 2). A reference
point corresponding to superior insertion of right and left ventricle wall
was also defined. Slices were classified as basal, middle, or apical by the
operator. Starting from the reference point, myocardiumwas divided in
120 micro sectors, and the metabolite signal in each micro sector was
evaluated. Finally, a polar map was constructed by reporting the signal
value in a “bull's eye” representation (Fig. 3). The polar map values
were averaged among six (basal and medium slices) or four (apical
slices) equiangular segments, and the values of metabolites concentra-
tion in corresponding segment of basal, middle, and apical slices were
averaged aswell leading to a 16-segmentsmodel ofmetabolite distribu-
tion, following the AHA guidelines [13].Fig. 2. Reconstructed short axis views of anatomical reference proton images (1H-Im) aTo semi-quantitatively analyze the segmental distribution of metab-
olites signal over the LV wall, the segmental variation map was defined
as ΔSi = 100 × (Si− Sg) / Sg, where Si (i = 1,…16) is the relative me-
tabolite signal in the segment i and Sg is the mean relative metabolite
signal over the entire LV. To assess the differences among different
conditions (i.e. basal, occlusion, reperfusion), the Metabolic Activity
Mismatch (MAM) between two segmental variation maps was defined
as MAM = 100(Sai − Sbi) / (Sai + Sbi) / 2, where Sai and Sbi are the
relative values of the signal ofmetabolite in the segment “i” in condition
“a” and “b”.
2.5. Hemodynamic study
Five additionalmale pigs (38±3 kg)were chronically instrumented
as previously described [14]. Briefly, a Doppler flow transducer (Craig
Hartley)was placed around the left anterior descending coronary artery
distally to the flow probe; the pneumatic vascular occluder was placed
below the second diagonal branch of the LAD. Coronary blood flow
was measured with a pulsed Doppler flowmeter (Model 100, Triton
Technology). Arterial pressure was measured via a fluid filled catheter,
while LV pressure, dP/dtmax and dP/dtmin were measured using a
solid state pressure gauge (Millar Instruments Inc, Houston TX, USA)
inserted percutaneously through the femoral artery and advanced
into the LV cavity under fluoroscopic guidance [15]. The analogic
signals were recorded through an analogic–digital interface (National
Instruments), at a sampling rate of 250 Hz [16]. At ten days following
thoracic surgery, the hemodynamic parameters were measured during
pyruvate injections at rest, during coronary occlusion and at 10′ of cor-
onary reperfusion after the second LAD occlusion. The animals were
then sacrificed as described above.
2.6. Statistical analysis
All data were analyzed using MedCalc software (v 12.1, MedCalc
Software, Mariakerke, Belgium).
The Kolmogorov–Smirnov test was employed to assess normality of
data distribution and for the residuals of regression models. Data are
presented asmean± standard error of themean (SEM),median and in-
terquartile range (IQR) and as proportions with percentage, as indicat-
ed. One-way repeated measures analysis of variance (ANOVA) was
used to evaluate whether there was a significant divergence between
different measurements. Bonferroni correction for multiple comparisonnd metabolic images (13C-bicarbonate images acquired in basal condition, 13C-Bic).
Fig. 3. Illustration of the image analysis procedure: In left panels, short axis view reconstruction of 13C-lactate (13C-Lac) and anatomical proton images (1H-Im); in the anatomical
images, the left ventricle was segmented and this segmentationwas automatically reproduced in the 13C-lactatemaps. Using this segmentation a bull's eye for 13C-lactatewas generated
(right panel).
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cant differences between groups. In all tests, a two-tailed p b 0.05 was
considered statistically significant.
3. Results
3.1. Coronary occlusion
Average MAM of lactate and bicarbonate at baseline and during oc-
clusion is shown in Fig. 4. ANOVA analysis revealed a significant depen-
dence of MAM from segmental location in both lactate (P b 0.001) and
bicarbonate (P b 0.001). As shown by the figure, the lactate distribution,
the average of metabolic change and the value of MAM detected in the
ischemic segments (middle anteroseptal and anterior wall and the
apical septum) were significantly different from of the remote regions
(inferior and inferolateral segments). As regards bicarbonate distribu-
tion ischemic segments were significantly different from the remote
segments.
This segmental localization of metabolic changes matched the re-
gional distribution of myocardial segments involved in the ischemicFig. 4.Metabolic Activity Mismatch (MAM) between basal and during coronary occlusion for
anterolateral; IL = inferolateral; I = inferior; IS = inferoseptal; S = septal.process as evidenced by the histologic evaluation with methylene blue
(Fig. 1).
3.2. Reperfusion after ten minutes occlusion
AverageMAM from all experiments in segmental distribution of lac-
tate and bicarbonate in either basal or reperfusion condition is shown in
Fig. 5. ANOVA analysis revealed significant inhomogeneity of MAM seg-
mental distribution of bicarbonate (P b 0.001). No significant difference
among segments was found in lactate distribution among segments
(P = 0.302). As regards bicarbonate distribution ischemic segments
were significantly different from the remote.
3.3. Hemodynamics
Heart rate and ECG were not significantly affected by the pyruvate
injections: as shown in Table 1, the hemodynamic parameters were
unchanged during the pyruvate injection as compared to the corre-
sponding value at each experimental condition (resting, occlusion and
reperfusion) before the pyruvate bolus injection.13C-lactate (left) and 13C-bicarbonate (right). AS = anteroseptal; A = anterior; AL =
Fig. 5.Metabolic Activity Mismatch (MAM) between basal condition and after reperfusion for 13C-lactate (left) and 13C-bicarbonate (right). AS= anteroseptal; A = anterior; AL= an-
terolateral; IL = inferolateral; I = inferior; IS = inferoseptal; S = septal.
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Myocardial regions of LVwere divided in the two clusters represent-
ed by segments involved by ischemic process at anatomical analysis and
remote segment metabolic activity. During occlusion, lactate distribu-
tion demonstrated a significantly lower MAM in ischemic segments
than in remote segments (−21 ± 6 vs 3 ± 5, P b 0.001). Bicarbonate
metabolic activity was lower in ischemic than in remote segments
(−29 ± 7 vs 33 ± 6, P b 0.0001).
Following reperfusion, a significant increase in lactate signal (20 ±
10vs−7±5, P=0.007) and a significant decrease of bicarbonate signal
(−38± 12 vs 36±11, P b 0.0001)was detected in segments affected by
occlusion than in remote segments.
The average extent of region metabolic mismatch during occlusion
was 12 ± 5% of LV mass. The extent of area at risk evaluated by
methylene blue was 14 ± 7% of LV mass. The mean difference of
extent between the area at risk assessed by methylene blue and by
hyperpolarized [1-13C]-pyruvate was 5 ± 2%.3.5. Inter-study reproducibility
The injection of hyperpolarized [1-13C]-pyruvate was repeated dur-
ing LAD occlusion in 4 pigs. The average variation of the extent of area at
risk in the same pigs, measured in different days was 6± 2% of LVmass.
During reperfusion, we obtained an average variation of 13-lactate ex-
tent of 10±4%. This greater differencemay be attributed to the changes
in haemodynamic parameters in ischemic conditions in different days.Table 1
Haemodynamic parameters.
Rest Rest
Pyruvate
Occlusio
CBF ml/min 30 ± 3.66 27 ± 3.62 6.1 ±
CSF nl/beat 0.29 ± 0.04 0.29 ± 0.05 0.07 ±
HeartRate, bpm 100 ± 8.24 96.4 ± 9.8 75.9 ±
SAP, mm Hg 118.17 ± 6.08 113.4 ± 7.99 102.2 ±
DAP, mm Hg 86.17 ± 4.4 85.7 ± 4.62 69.2 ±
MAP, mm Hg 104.6 ± 5.16 103.2 ± 5.86 86 ±
LVESP, mm Hg 117.7 ± 6.16 112.87 ± 8.13 100 ±
LVEDP, mm Hg 1.43 ± 0.57 1.95 ± 0.73 1.55 ±
LVdP/dtmax, mm Hg/s 2468.62 ± 203.1 2238.6 ± 196 1584 ±
LVdP/dtmin, mm Hg/s −1704.3 ± 190.7 −1551 ± 218 −1004 ±
Mean values± SEM; CBF, coronary blood flow; CSF, coronary stroke flow; SAP, systolic arterial
ular end-systolic pressure; LVEDP, left ventricular end-diastolic pressure. ⁎P b .05 vs baseline.4. Discussion
The present study shows that MRI with hyperpolarized [1-13C]-
pyruvate using a 3D-IDEAL Spiral CSI pulse sequences can provide
an accurate evaluation of pyruvate, lactate and bicarbonate distribu-
tion in either normoperfused or ischemic myocardium, in an animal
model mirroring a clinically relevant condition.
In the healthy heart, 60% to 90% energy production is achieved from
beta-oxidation of fatty acids, while mainly from pyruvate oxidation for
the remainder [17]. Pyruvate is a centralmetabolic substrate linking gly-
colysis to the Krebs cycle, and leading to energy production, as well as
to production of lactate and CO2, partly converted in bicarbonate. Pyru-
vate derives from cytosolic glycolysis and lactate oxidation and, in the
normoperfused heart, is mostly oxidized in the Krebs cycle, to form
CO2, and partly either reduced back to lactate or converted into alanine
[18].
Magnetic resonance with hyperpolarized 13C-pyruvate allows in-
vivo evaluation of relative changes of pyruvate metabolites as lactate,
bicarbonate and alanine [3]. Metabolic evaluation may be clinically rel-
evant in ischemic heart disease, as well as in cardiomyopathy.
However, the objective of the current study was to test the sensitiv-
ity of the employed methodology in detecting areas of ischemia during
coronary occlusion and eventually the subsequent restoration ofmetab-
olism during the reperfusion phase. The main finding is the demonstra-
tion that spatial resolution obtained using a 3D-IDEAL Spiral CSI pulse
sequence was high enough to provide three-dimensional information
of acute changes of pyruvate andmetabolites in left ventricularmyocar-
dium using the conventional on a regional segmentation. Moreover, an Occlusion
Pyruvate
Reperfusion Reperfusion
Pyruvate
0.55⁎ 10.2 ± 3⁎ 25.4 ± 2.2 24.3 ± 2.53
0.006⁎ 0.09 ± 0.01⁎ 0.29 ± 0.04 0.28 ± 0.02
7.59⁎ 72.3 ± 7.3⁎ 93.6 ± 18.5 95.4 ± 15.2
13.5 100.5 ± 15.4 124.7 ± 35.3 122.4 ± 30.2
11.5⁎ 66.3 ± 12.4⁎ 86.5 ± 25.1 83 ± 22.5
12.4⁎ 77.7 ± 11.5⁎ 105.5 ± 29.2 98.5 ± 25.4
14 101 ± 12 122 ± 34.6 120 ± 33.4
0.5 2.05 ± 0.8 5 ± 3 6.2 ± 2.8
225⁎ 1597 ± 213⁎ 2626 ± 1217 2611 ± 1110
318⁎ −1010 ± 330⁎ −1245.2 ± 412 −1250 ± 422
pressure; DAP, diastolic arterial pressure; MAP, mean arterial pressure; LVESP, left ventric-
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dencedwithmethylene blue at histology and the regionswithmetabol-
ic changes at MRI was found.
During acute coronary occlusion no signal related to pyruvate me-
tabolites was detected in the involved myocardial segments. This was
expected, as in such condition the 13C-labeled substrate could not
reach the myocardial area at risk because the absence of perfusion pre-
vents the arrival of exogenous pyruvate to the myocardium and, obvi-
ously, metabolism of endogenous pyruvate was not evaluable by the
present approach.
Myocardial uptake of [1-13C]-pyruvate occurs during the reperfu-
sion phase and changes in metabolites may be detected. In fact, lactate
production was slightly increased during reperfusion, while the bicar-
bonate production was significantly reduced within the area at risk.
Based on these results we might speculate that, after 5 min of reperfu-
sion following 10 min of occlusion, the oxidative metabolism was still
impaired, showing typical alterations associated with acute ischemia.
MRIwith hyperpolarized 13-C technique does not permit a quantita-
tive assessment of metabolites concentration, but only the appreciation
of relative changes of pyruvate and its metabolites. In the current study,
we evaluated the signal of each myocardial segment in the reconstruct-
ed metabolic maps as the difference between the signal of the each seg-
ment and the average signal of the entire myocardium, expressed as
percentage of the average signal of the entire myocardium. Therefore,
theMAM indexwas used to evaluate the variations of metabolite signal
of the samemyocardial segment in different conditions (either coronary
occlusion or reperfusion versus baseline).
On the technical point of view, in the current study we used the
IDEAL spiral CSI method which is different from previously presented
approaches. In the study by Golman a single slice 13C chemical shift im-
ages in a single short-axis viewmidway through the long axis of the left
ventricle with a slice thickness of 20 mm, and a two-dimensional pixel
size of 7.5 × 7.5 mm was used [7]. Lau et al. already described a multi-
slice cardiac-gated spiral 13C imaging pulse sequence consisting of
a large permitting whole-heart coverage [8]. However, differently
from the above mentioned technique, in the IDEAL spiral CSI method
the spectra are not just assumed to be sparse but that the spectral
sparsity is used as prior knowledge and then effectively utilized in the
reconstruction process, where it allows mapping of the full spectrum
rather than a limited number of peaks at certain prescribed frequencies
[10]. Thus, the IDEAL spiral CSI pulse sequence permits to get the com-
plete 3D-dataset of information, with optimal signal to noise ratio and
with short acquisition time (17 seconds), for each metabolites simulta-
neously. This might be potentially relevant for the application of
hyperpolarized [1-13C]-pyruvate in human allowing complete acquisi-
tion during one breath-hold and then permitting to minimize the arti-
fact from respiratory motion.
Recently Schroeder et al. evaluate myocardial metabolism with
hyperpolarized [1-13C]-pyruvate in a pig model of pacing induced
heart failure using a surface phased array coil [19]. Surface coil allows
increase of signal from the cardiac structure next to the coil but
produces signal decrease of the distant region as the inferiormyocardial
segments of LV. In the current study we performed hyperpolarized
[1-13C]-pyruvate acquisition using a volumetric bird-cage coil which
allowed a more homogeneous signal in all the myocardial sections.
Large dose injection of pyruvate could have a pharmacodynamic ef-
fect that should be considered [20]. In this study, heart rate and ECG
were not significantly affected by the pyruvate injections (see
Table 1). The same findings have been reported by Goldman et al. [9]
with a dose of 300 mM of pyruvate. Moreover, a study by Atherton
et al. [3] provided the evidence that even after an elevated plasma
peak of pyruvate no significant alteration in the concentration of
glucose, insulin, lactate, β-idroxybutyrate, triacylglyceride and non es-
terified fatty acids were detected during the MRS time frame experi-
ments. Moreover, we analyzed in a previous study [4] the cardiac
spectroscopic signal after the infusion of 230 mM of hyperpolarizedpyruvate at rest and during inotropic stress. We have shown that the
cardiac work increased the signal of lactate and bicarbonate, leading
to a two-fold increase in the apparent enzymatic kinetic constants in
non-steady state conditions. This finding parallels with a two-fold in-
crease in the rate-pressure product stress versus rest, an indirect param-
eter of cardiac oxygen consumption during inotropic stress, and could
partially exclude enzyme saturation effects.
Some limitations of this study should bementioned: pulse sequence
used to acquire images was not ECG-triggered. This approach might
have caused motion artifacts and conditioned the spatial resolution;
however, the signal was acquired throughout the whole cardiac cycle
to increase the SNR, also considering the fast signal decay which is in-
trinsic to the use of hyperpolarized substrates. In fact, the signal of mag-
netization undergoes an exponential decay with typical time constants
(T1, spin lattice relaxation time) of about 60 s.
For these reasons, at present, we were forced to use the whole
allowed time to get enough signal from the myocardium.
Another limitation was that only changes in bicarbonate and lactate
were assessed, while alanine changes were not systematically detected.
In fact, the alanine signal resulted rather low and in some segments was
not detectable, due to a low signal to noise ratio. This limitation was the
consequence of evaluation of cardiac metabolism using a whole-heart
three dimensional approach and using a birdcage volumetric coil.
Further studies are needed to verify if these limitations can be over-
come, using a surface coil to improve the SNR, aswell as an accurate ECG
triggering might allow a better identification of regional metabolic
changes.
5. Conclusions
This study shows that a three-dimensional evaluation of cardiacme-
tabolismwith 13C hyperpolarized pyruvate is feasible in a large size an-
imalmodel of ischemia and reperfusion. A good topographic correlation
on segmental basis was found between spectroscopic imaging maps
and gross anatomical analysis. The Food and Drug Administration re-
cently approved the use of hyperpolarized 13C-pyruvate for clinical
studies of prostate cancer. Previous studies and the present one point
to the possibility that, in the near future, H13C-tracing may be used as
a powerful diagnostic tool in the cardiovascular field.
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